返回
Repligen Corp（RGEN）价格
RGEN 股价走势图
RGEN 收益
Repligen Corp
$162.02
0.2%
$0.33
收盘价：Jan 16, 16:00:00 GMT-5
$162.02
0%
$0
盘后：Jan 16, 20:00:00 GMT-5
关键数据
前收盘价
$161.69
开盘价
$162.29
当日区间
$161.16 - $165.15
52周范围
$102.96 - $182.52
交易量
625.0K
平均成交量
840.8K
每股收益（TTM）
0.03
股息收益率
--
市值
$9.1B
什么是 RGEN？
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. The company is headquartered in Waltham, Massachusetts and currently employs 1,778 full-time employees. Its focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. Its chromatography franchise includes several products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. Its TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes. Its desktop portfolio includes MAVERICK and MAVEN, REBEL, and ZipChip.